Solving some of the world’s greatest health challenges
Neurovalens is a global health-tech company that creates non-invasive neurostimulation products used to solve some of the world’s greatest health challenges.
Our medical device technology offers unparalleled transdermal activation of the homeostatic nuclei of the brainstem and hypothalamus, allowing for alterations in autonomic function, circadian regulation and Neuro-metabolic influence.
Our core values hinge on the generation of robust clinical data that provide meaningful outcomes throughout the lives of our patients. Neurovalens technology aims to provide drug-free solutions to the worlds, greatest health epidemics.

Merging Neuroscience & Technology
Applications for Neurovalens Technology
Latest News
The Sunday Times | Sir Richard Branson & co pick their start-ups of 2019
These are the start-ups that most impressed Britain’s top entrepreneurs and investors in 2019. There was a technology theme to the selections, while several on our panel of small business champions picked companies, they claimed were tackling some of the world’s biggest problems by treating Alzheimer’s disease and broadening access to education.
The Irish News | Latest cash injection sees medical tech firm Neurovalens target US growth
A BELFAST technology firm developing a number of specialised medical devices has received its second major cash injection in a month.
Neurovalens has been boosted by £750,000 from the Growth Finance Fund to support the launch of a new sleep product in the USA later this year.
Belfast Newsletter | Health tech company creates 22 new jobs
Belfast-based health tech company Neurovalens is set to create 22 new jobs with the development of a ground-breaking medical device.
Neurovalens, a global leader of neuro-technology products, is embarking on the development of a device for the treatment of obesity with £1m support from Invest NI. The technology is based on the neuro stimulation of specific areas of the brain responsible for influencing appetite and cravings.